India Seeks to Quash Adani's Nicotine Pouch Challenge, Citing Health Risk
PM sits 28% above its 52-week low of $142.11.
Summary
The Indian government is seeking to dismiss Adani Group's court challenge over the sale of nicotine pouches at Mumbai airport, arguing the sales are a 'substantive violation' of drug laws and a 'serious public health risk.' The case directly involves Philip Morris' Zyn pouches, which Adani imported. A ruling against Adani could set a precedent restricting duty-free sales of nicotine pouches in India, a key growth market for PM's smoke-free products. This follows the FDA's recent authorization of Zyn as a less harmful alternative in the U.S., highlighting contrasting regulatory trajectories. The Mumbai High Court hearing is scheduled for Tuesday.
At the time of this announcement, PM was trading at $181.84 on NYSE in the Trade & Services sector, with a market capitalization of approximately $283.1B. The 52-week trading range was $142.11 to $193.05. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.